Clinical Trial Update: A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effects of Darapladib in subjects with Diabetic Macular Edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Darapladib (darapladib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Retinopathy, Diabetic | Phase 2 | Status: COMPLETED